A new European headquarters has been acquired for BioMarin Europe Limited on Shaftesbury Avenue, London, WC2. The company is a division of the parent company BioMarin Pharmaceutical Inc who are based in the US and have been operating for 10 years.
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
